If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
The telehealth platform’s shares jumped more than 40% after the news that it will sell Ozempic and Wegovy—and no longer faces a lawsuit from the Danish pharma giant. If you don't have a login or your ...
To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved. For multi-user ...
With IWD approaching, WIPR urges practitioners to submit nominations for its Influential Women in IP list, recognising ...
27 February 2026 The companies have agreed to dismiss their long-running patent fight over tumour-informed liquid biopsy ...
A former Pinsent Masons partner has joined the firm’s London office, boosting the team’s capabilities in high-value life ...
As the firm expands its IP offering, “an unusually versatile lawyer” with chemical, biologics, and medical device spaces ...
26 February 2026 As the US Supreme Court prepares to hear arguments in the Hikma and Amarin dispute, the case has drawn a ...
The healthcare company’s chief IP counsel is researching how law firms and patent attorneys are using AI tools to inform its own guidelines for external legal providers. If you don't have a login or ...
As the US Supreme Court prepares to hear arguments in the Hikma and Amarin dispute, the case has drawn a broad coalition of ...
Launch forms part of the firm’s continued national growth strategy, boosting its presence in “a vibrant ecosystem of technology, life sciences, wireless communications and emerging growth companies”.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results